Silvia Rabar senior research fellow and project manager, Martin Harker senior health economist, Norma O’Flynn clinical director and guideline lead, Anthony S Wierzbicki professor of cardiometabolic disease
Rabar S, Harker M, OâFlynn N, Wierzbicki A S.
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
BMJ 2014; 349 :g4356
doi:10.1136/bmj.g4356